India develops its first indigenous antibiotic Nafithromycin, a DBT-Wockhardt collaboration effective against resistant respiratory infections.
Read MoreDepartment of Biotechnology
Pharma Exports Near USD 30 Billion as India Strengthens Biotech and MedTech Ecosystem
India’s pharma exports are set to cross $30 billion by year-end, with the domestic market projected to reach $130 billion by 2030.
Read More
Cabinet Approves Phase III of Biomedical Research Career Programme with INR 1,500 Cr Investment
Cabinet approves Phase III of the Biomedical Research Career Programme with ₹1,500 crore funding to nurture talent, research capacity, and global biomedical impact.
Read More
India Sets USD 300 Billion Bioeconomy Goal by 2030
India’s bioeconomy narrative is being rewritten as inclusive, impactful, and innovation-led.
Read More